Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Rev. esp. anestesiol. reanim ; 65(4): 229-233, abr. 2018. ilus
Artigo em Espanhol | IBECS | ID: ibc-177054

RESUMO

Un hematoma retrofaríngeo es una situación clínica que puede poner en peligro la vida por la potencial obstrucción de la vía aérea superior y que requiere un rápido diagnóstico. Puede presentarse clínicamente de diferentes formas, según el tamaño y la velocidad en su desarrollo. La primera medida a tener en cuenta es la protección y el manejo de la vía aérea que, en la mayoría de las veces, es una situación de vía aérea difícil. En la aparición de un hematoma retrofaríngeo puede existir un antecedente traumático previo, con o sin fractura cervical asociada. El tratamiento del hematoma en la mayoría de los casos es conservador, con una estrecha vigilancia hasta su reabsorción en 3-4 semanas, aunque en ocasiones precisa de evacuación quirúrgica. Presentamos el caso clínico de un paciente que desarrolló un gran hematoma retrofaríngeo tras traumatismo cervical menor y describimos el abordaje de la vía aérea mediante el uso del laringoscopio óptico desechable Airtraq(R)


Retropharyngeal haematoma is a life-threatening clinical situation that can lead to a potential obstruction of the upper airway and requires rapid diagnosis. Clinicaly, it can be presented in different ways, depending on its size and growing speed. The first measure is to protect and manage the airway: in most cases this is a difficult airway situation. A retropharyngeal haematoma can be formed due to a previous traumatic history, with or without associated cervical fracture. Treatment of the haematoma is conservative in most cases, with close monitoring until it is reabsorbed in 3-4 weeks, although they can sometimes require surgical evacuation. We present the case of a patient who developed a large retropharyngeal haematoma after minor cervical trauma and describe an approach of the airway using the Airtraq(R) disposable optical laryngoscope


Assuntos
Humanos , Masculino , Idoso de 80 Anos ou mais , Faringe/lesões , Manuseio das Vias Aéreas/métodos , Lesões do Pescoço/complicações , Hematoma/etiologia , Anestésicos/administração & dosagem , Laringoscopia/métodos , Obstrução das Vias Respiratórias/complicações , Diagnóstico Tardio , Hipofaringe/lesões , Anestesia/métodos , Transtornos de Deglutição/etiologia
2.
Rev Esp Anestesiol Reanim (Engl Ed) ; 65(4): 229-233, 2018 Apr.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-29242030

RESUMO

Retropharyngeal haematoma is a life-threatening clinical situation that can lead to a potential obstruction of the upper airway and requires rapid diagnosis. Clinicaly, it can be presented in different ways, depending on its size and growing speed. The first measure is to protect and manage the airway: in most cases this is a difficult airway situation. A retropharyngeal haematoma can be formed due to a previous traumatic history, with or without associated cervical fracture. Treatment of the haematoma is conservative in most cases, with close monitoring until it is reabsorbed in 3-4 weeks, although they can sometimes require surgical evacuation. We present the case of a patient who developed a large retropharyngeal haematoma after minor cervical trauma and describe an approach of the airway using the Airtraq® disposable optical laryngoscope.


Assuntos
Manuseio das Vias Aéreas/instrumentação , Hematoma/terapia , Laringoscópios , Doenças Faríngeas/terapia , Acidentes por Quedas , Idoso de 80 Anos ou mais , Manuseio das Vias Aéreas/métodos , Braquetes , Vértebras Cervicais/lesões , Sedação Consciente , Tratamento Conservador , Transtornos de Deglutição/etiologia , Diagnóstico Tardio , Dispneia/etiologia , Traumatismos Faciais/complicações , Hematoma/diagnóstico por imagem , Hematoma/etiologia , Humanos , Intubação Gastrointestinal , Masculino , Lesões do Pescoço/complicações , Doenças Faríngeas/diagnóstico por imagem , Doenças Faríngeas/etiologia , Fraturas da Coluna Vertebral/etiologia
3.
Rev Esp Enferm Dig ; 103(1): 5-12, 2011 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-21341931

RESUMO

OBJECTIVE: Analysis and evaluation of a multidisciplinary approach, postoperative results and survival of a group of patients with resected pancreatic cancer after a multimodal therapy. DESIGN: DESCRIPTIVE, prospective and observational study. PATIENTS: Between January 2004 and December 2004, 124 patients with pancreatic cancer were evaluated. In 30 patients pancreatic resection was performed, and they are the object of this study. Results of preoperative evaluation, postoperative morbidity and mortality, and long term survival were studied. RESULTS: Diagnostic evaluation was completed in ambulatory basis in 20% of the patients. In 63% of cases, admission was done in the same day of surgery. In 3 patients (9%), tumor resection was not achieved, therefore, concordance between radiological and surgical resectability rate was 91%. Resectability rate was 24.1%. Surgical Mortality was 3.3%, with a global morbidity rate of 56.6%. Survival at one, two, three and, four years was 76.2%, 56.3%, 43%, y 27.3% respectively. CONCLUSIONS: Technological development and coordination of efforts in multidisciplinary teams offer an accurate evaluation of tumor involvement, and may reduce the number of laparotomies without tumor resection. The application of a systematic and generalized multimodal treatment in pancreatic cancer is progressively showing a tendency of progressive increase in resectability and survival rates in pancreatic cancer.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Carcinoma Ductal Pancreático/terapia , Pancreatectomia/métodos , Neoplasias Pancreáticas/terapia , Equipe de Assistência ao Paciente , Adulto , Idoso , Idoso de 80 Anos ou mais , Carcinoma/diagnóstico , Carcinoma/diagnóstico por imagem , Carcinoma/patologia , Carcinoma/terapia , Carcinoma Ductal Pancreático/diagnóstico , Carcinoma Ductal Pancreático/diagnóstico por imagem , Carcinoma Ductal Pancreático/patologia , Carcinoma Ductal Pancreático/secundário , Quimioterapia Adjuvante , Colangiopancreatografia Retrógrada Endoscópica , Colectomia , Terapia Combinada , Desoxicitidina/administração & dosagem , Desoxicitidina/análogos & derivados , Diagnóstico por Imagem , Feminino , Hepatectomia/métodos , Humanos , Estimativa de Kaplan-Meier , Neoplasias Hepáticas/secundário , Neoplasias Hepáticas/cirurgia , Masculino , Pessoa de Meia-Idade , Terapia Neoadjuvante , Compostos Organoplatínicos/administração & dosagem , Oxaliplatina , Pancreatectomia/mortalidade , Neoplasias Pancreáticas/diagnóstico , Neoplasias Pancreáticas/diagnóstico por imagem , Neoplasias Pancreáticas/patologia , Pancreaticoduodenectomia , Estudos Prospectivos , Stents , Taxa de Sobrevida , Gencitabina
4.
Rev. esp. enferm. dig ; 103(1): 5-12, ene. 2011. tab, ilus
Artigo em Espanhol | IBECS | ID: ibc-84891

RESUMO

Objetivo: analizar la evaluación del abordaje multidisciplinario de un grupo de pacientes con cáncer de páncreas resecado, los resultados postoperatorios y la supervivencia tras la aplicación de un tratamiento multimodal. Diseño: estudio descriptivo prospectivo observacional. Pacientes: entre enero de 2004 y diciembre 2009 se evaluaron 124 pacientes con cáncer de páncreas. De ellos, se realizó la resección pancreática con intención curativa en 30 casos que constituyen el objeto del estudio. Se analizaron los resultados del estudio preoperatorio de extensión tumoral, la morbi-mortalidad postoperatoria, y la supervivencia. Resultados: la evaluación diagnóstica se hizo en régimen ambulatorio en el 20% de los pacientes. En el 63% de los casos, el ingreso fue el mismo día de la intervención. En 3 pacientes intervenidos no se consiguió realizar la resección del tumor (9%), por lo que la tasa de concordancia entre la resecabilidad radiológica y la quirúrgica fue del 91%. La tasa de resecabilidad quirúrgica fue del 24,1%. La mortalidad quirúrgica de la serie fue de un 3,3%, con una morbilidad global del 56,6%. La supervivencia al año, dos, tres y cuatro años fue del 76,2%, 56,3%, 43%, y 27,3% respectivamente. Conclusiones: el desarrollo tecnológico y la evaluación multidisciplinar coordinada, permite realizar una evaluación precisa de la extensión tumoral, y puede reducir el número de laparotomías sin resección del tumor. Con la aplicación de una terapia multimodal sistemática combinada, la resecabilidad quirúrgica y la supervivencia a medio y largo plazo parece que están aumentando de forma progresiva(AU)


Objective: analysis and evaluation of a multidisciplinary approach, postoperative results and survival of a group of patients with resected pancreatic cancer after a multimodal therapy. Design: descriptive, prospective and observational study. Patients: between January 2004 and December 2004, 124 patients with pancreatic cancer were evaluated. In 30 patients pancreatic resection was performed, and they are the object of this study. Results of preoperative evaluation, postoperative morbidity and mortality, and long term survival were studied. Results: diagnostic evaluation was completed in ambulatory basis in 20% of the patients. In 63% of cases, admission was done in the same day of surgery. In 3 patients (9%), tumor resection was not achieved, therefore, concordance between radiological and surgical resectability rate was 91%. Resectability rate was 24.1%. Surgical Mortality was 3.3%, with a global morbidity rate of 56.6%. Survival at one, two, three and, four years was 76.2%, 56.3%, 43%, y 27.3% respectively. Conclusions: technological development and coordination of efforts in multidisciplinary teams offer an accurate evaluation of tumor involvement, and may reduce the number of laparotomies without tumor resection. The application of a systematic and generalized multimodal treatment in pancreatic cancer is progressively showing a tendency of progressive increase in resectability and survival rates in pancreatic cancer(AU)


Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Terapia Combinada/tendências , Terapia Combinada , Sinais e Sintomas , Neoplasias Pancreáticas/diagnóstico , Neoplasias Pancreáticas/terapia , /tendências , Excisão de Linfonodo , Adjuvantes Farmacêuticos/uso terapêutico , Pancreatectomia/métodos , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Indicadores de Morbimortalidade , Cuidados Pós-Operatórios/tendências , Fístula/terapia , Pancreatectomia/tendências , Pancreatectomia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA